Home › Epidermolysis Bullosa Dystrophica › NCT01019148
Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria: * Clinical diagnosis of RDEB by local dermatologist * 7 years of age or older Exclusion Criteria: -Medical instability limiting ability to travel to Stanford University Medical Center
About the study
Recessive dystrophic epidermolysis bullosa (RDEB) is a disease caused by genetic mutations in the gene for type VII collagen. Patients with RDEB develop large, severely painful blisters and open wounds from minor trauma to their skin. We are screening subjects with RDEB to evaluate characteristics of the subjects and their cells in order to develop new strategies of therapy and determine whether subjects could be candidates for treatment studies.
Sponsor: Stanford University · Participants: 70 · Started: Nov 10, 2009
Contact the study team
- Irene Bailey-Healy · Phone: (650) 721-7149
Official record on ClinicalTrials.gov — NCT01019148
Locations in the U.S.
| California | Stanford University School of Medicine, Stanford |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.